Healthcare / Medical DistributionThailand
$0.90
+0.00 (+0.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 18%
FCF escenarios
weak_data · normalized FCF $438.2M · quality 45.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
29/100
D
Piotroski
8/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$277M
P/E
30.0x
↑EV/EBITDA
6.8x
↓ROE
6.7%
↑Gross Margin
35.5%
↓Debt/Equity
0.78
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+3.1%
FCF CAGR
—
FCF margin
62.1%
FCF / Net income
15.93x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $705.2M · net income $27.5M · FCF $438.2M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $705.2M | $705.2M | $725.2M | $696.0M | $642.9M |
| Net Income | $27.5M | $27.5M | $-21.6M | $-4.5M | $13.0M |
| EBITDA | $82.3M | $82.3M | $31.9M | $46.7M | $43.6M |
| EPS | 0.09 | 0.09 | -0.07 | -0.01 | 0.04 |
| Gross Margin | 35.5% | 35.5% | 31.8% | 33.1% | 35.5% |
| Operating Margin | 6.5% | 6.5% | -1.5% | 0.9% | 2.9% |
| Net Margin | 3.9% | 3.9% | -3.0% | -0.6% | 2.0% |
| Balance Sheet | |||||
| Debt/Equity | 0.78 | 0.78 | 0.92 | 0.94 | 0.71 |
| Current Ratio | 1.48 | 1.48 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $438.2M | $438.2M | $453.9M | $-72.0M | $-112.5M |
| Returns | |||||
| ROE | 6.7% | 6.7% | -5.7% | -1.1% | 3.0% |
| Valuation | |||||
| P/E | 30.00 | 30.00 | — | — | 64.25 |
| EV/EBITDA | 6.80 | 6.80 | 32.04 | 22.00 | 23.89 |
| P/B | 0.67 | 0.67 | 1.88 | 1.74 | 1.94 |
| Growth & Yield | |||||
| Revenue Growth | -2.8% | -2.8% | 4.2% | 8.3% | — |
| EPS Growth | 227.0% | 227.0% | -381.5% | -135.3% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
-3.7%
EPS terminal req.
$0.08
Spread vs growth
230.7%
5Y implied EPS CAGR
1.6%
EPS terminal req.
$0.10
Spread vs growth
225.4%
10Y implied EPS CAGR
5.7%
EPS terminal req.
$0.16
Spread vs growth
221.3%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+0.0%
Start / end P/E
n/dx → n/dx
EPS bridge
-0.07 → 0.09
Residual
+0.0%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.